Co-payment policies and breast and cervical cancer screening in Medicaid.

Co-payment policies and breast and cervical cancer screening in Medicaid.
复制标题

DOI:
10.37765/ajmc.2020.42395
复制
发表时间:
2020-02
期刊:
The American journal of managed care
影响因子:
--
通讯作者:
Bradley CJ
Bradley CJ
中科院分区:
其他
文献类型:
--
作者:
Sabik LM;Vichare AM;Dahman B;Bradley CJ

文献摘要

参考文献

被引文献

相似文献

This study investigates the relationship between state Medicaid co-payment policies and cancer screening for Medicaid-enrolled women. Cross-sectional analysis of administrative claims and enrollment data. Our data included Medicaid Analytic eXtract outpatient claims files across 43 states in 2003, 2008 and 2010, the years for which both MAX data and state cost-sharing data were available. Data on enrollee demographics and screening services from enrollment and claims files are merged with state-year data on co-payment policies and county-level controls from the Area Health Resources File. Participants were non-elderly, non-disabled, non-pregnant women in the recommended age range for each screening service (50–64 years for mammograms; 21–64 years for Pap tests) enrolled in fee-for-service Medicaid. The main independent variable is whether an enrollee faces cost-sharing for preventive services. We examine three categories of cost-sharing: co-payments for all visits, including for preventive services; co-payments for outpatient visits, but waived for preventive services; and no co-payments. The main outcome measure was receipt of mammogram or Pap test within a 12-month period. Medicaid enrollees with copayments for preventive services were less likely to receive both screening mammograms and Pap tests than enrollees in states not requiring cost-sharing for preventive services. Co-payments for preventive services discourage breast and cervical cancer screening among Medicaid enrollees. The effect is larger for breast cancer screening, which is costlier and requires an additional visit. Considering this evidence, cost sharing for preventive services may lead to adverse health consequences and greater long-term costs. Co-payments for preventive services can discourage breast and cervical cancer screening among Medicaid enrollees, particularly breast cancer screening, which is more costly and time consuming.
DOI: 10.1056/nejmoa1206809
发表时间: 2012-11-22
影响因子: 158.5
作者:
Bleyer, Archie;Welch, H. Gilbert
通讯作者: Welch, H. Gilbert
DOI: 10.1002/hec.3164
发表时间: 2016-05-01
期刊: HEALTH ECONOMICS
影响因子: 2.1
作者:
Sabik, Lindsay M.;Gandhi, Sabina Ohri
通讯作者: Gandhi, Sabina Ohri
DOI: 10.1377/hlthaff.2008.0701
发表时间: 2010-09-01
期刊: HEALTH AFFAIRS
影响因子: 9.7
作者:
Maciosek, Michael V.;Coffield, Ashley B.;Solberg, Leif I.
通讯作者: Solberg, Leif I.
DOI: 10.1016/s1470-2045(08)70032-9
发表时间: 2008-03-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Halpern, Michael T.;Ward, Elizabeth M.;Chen, Amy Y.
通讯作者: Chen, Amy Y.
DOI: 10.1016/s0027-9684(15)30409-0
发表时间: 2011-08-01
影响因子: 3.3
作者:
Hendren, Samantha;Chin, Nancy;Fiscella, Kevin
通讯作者: Fiscella, Kevin